查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1832505

白內障手術設備市場：按產品類型、技術和最終用戶 - 全球預測 2025-2032

Cataract Surgery Devices Market by Product Type, Technology, End User - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，白內障手術設備市場將成長至 149.3 億美元，複合年成長率為 8.30%。

主要市場統計數據
基準年2024年 78.8億美元
預計2025年 85.3億美元
預測年份：2032年 149.3億美元
複合年成長率（%） 8.30%

從臨床創新、不斷變化的醫療環境和採購需求的角度來看待不斷發展的白內障手術設備市場

白內障手術器材在外科創新、人口需求和不斷發展的醫療保健服務的交匯處佔據關鍵地位。在過去十年中，該領域已從依賴傳統的乳化和單焦點晶狀體發展到更多樣化的選擇，旨在改善屈光效果、縮短恢復時間並擴大手術的安全環境。這些進步得益於影像處理、雷射精度、人工水晶體設計以及旨在保護眼組織和最佳化術中操作的耗材的同步進步。

因此，臨床團隊、採購主管和設備製造商面臨著一個這樣的情況：互通性、可預測的供應鏈以及與臨床結果緊密相關的清晰價值命題將獲得回報。隨著治療途徑從中心醫院轉向門診手術中心和專科眼科診所，設備的選擇擴大反映手術量、與現有平台的兼容性以及對新興屈光技術的支持。在此背景下，仔細綜合設備效能、監管趨勢和最終用戶偏好對於制定採購策略、臨床應用和產品開發藍圖至關重要。

精密雷射、多樣化的人工水晶體結構以及分散的醫療保健服務如何重新定義臨床實踐和供應商策略

白內障手術設備領域正在經歷數次變革，這些變革正在再形成臨床通訊協定、供應商策略和投資重點。首先，精準引導的飛秒雷射系統正在改變手動操作的作用，使其能夠實現更可重複的囊膜切口和精準的弧形切口，從而影響高階人工水晶體的選擇和屈光結果的預期。同時，人工水晶體的設計也正在從單焦光學元件向擴展景深、多焦、散光和高度非球面鏡片等多樣化發展，從而擴大了患者群體，並促進了圍繞高階護理的報銷談判。

同時，白內障治療正轉向門診手術中心和高容量眼科診所，在這些地方，吞吐量和設備相容性與設備性能同等重要。這種分散化趨勢促使設備製造商優先考慮模組化系統、精簡的耗材物流以及旨在降低手術結果差異性的培訓方案。最後，數位化整合正在成為一項差異化因素，涵蓋從手術全期影像到手術規劃軟體，再到與電子健康記錄的互通性。總而言之，這些轉變有利於那些能夠展現卓越臨床表現、經濟清晰性以及無縫融入不同護理途徑能力的供應商。

檢驗2025 年美國關稅對營運和採購的影響，以及對設備採購和臨床採用的影響

近期的關稅行動以及美國2025年更廣泛的貿易政策環境，對整個白內障手術供應鏈產生了重大波動，促使製造商和醫療保健提供者重新評估籌資策略和成本結構。由於許多醫療設備和關鍵零件在多個地區生產，進口關稅的提高引發了各種應對措施。一些供應商暫時吸收成本以維持市場進入，另一些供應商則將採購轉向國內或享受關稅豁免的供應商，還有一些供應商加快了關鍵組件的本地化進程。因此，採購計劃和供應商談判現在納入了更清晰的緊急條款和近期風險評估。

除了直接的成本影響外，關稅還透過改變高階人工水晶體、飛秒雷射模組和高階乳化主機的相對定價，影響了臨床應用途徑。尋求可預測預算的醫療保健系統高度重視多年期服務合約和捆綁定價，而門診中心則強調每個總成本和耗材的可用性。重要的是，監管協調和加快清關流程成為營運槓桿。擁有強大合規文件、本地倉儲和快速更換能力的製造商獲得了競爭優勢。除非貿易政策穩定下來，否則這種動態可能會持續下去，這凸顯了籌資策略中建立多元化供應商關係和透明定價模式的必要性。

詳細的細分洞察，展示產品類型、技術工作流程和護理環境如何推動採用模式、培訓需求和採購優先級

關鍵細分洞察揭示了產品設計、手術技術和最終用戶偏好如何影響白內障手術器械的採用模式和投資重點。首先，檢視產品類型可以發現，產品類型涵蓋了從飛秒雷射系統等資本密集平台到耗材和超音波乳化機主機等一系列產品。人工水晶體在這一頻譜佔據核心地位，並進一步細分為用於最佳化影像品質的非球面設計、用於增強功能性視野的擴展景深鏡片、實用的預設單光鏡片、用於不戴眼鏡的多焦點解決方案以及用於矯正散光的散光鏡片。每個子類別都有不同的臨床訓練要求，並影響術後患者滿意度指標。

從技術層面來看，囊外白內障摘除術與飛秒雷射輔助手術、小切口技術和乳化/抽吸等更先進的手術方法之間存在明顯差異。在飛秒輔助工作流程中，用於散光管理的弓形切口、用於穩定晶狀體聚焦的囊切開術以及用於降低晶狀體能量的晶狀體碎裂術等手術模組推動著互補設備採購和手術標準化。門診手術中心和眼科診所通常優先考慮吞吐量、設備佔地面積和耗材物流，而眼科研究機構則強調研究級的多功能性和臨床試驗準備度，醫院則重視服務的廣度和跨專業整合。這些細分軸線相互契合，表明成功的商業策略必須將產品模組化、培訓支援和服務模式與每個臨床環境獨特的營運現實相結合。

美洲、歐洲、中東和非洲以及亞太地區的報銷模式、手術量和基礎設施的差異如何影響設備策略

在全球白內障生態系統中，區域動態仍然是決定設備銷售策略和商業化方法的關鍵因素。在美洲，強大的私人支付方參與度加上廣泛的門診手術中心網路，催生了對能夠提供高效吞吐、可預測結果和強大售後服務的設備的需求。相反，美洲的機構投資者通常需要整合的平台相容性和清晰的臨床經濟效益來支持資本投資決策。放眼歐洲、中東和非洲，該地區的法規環境和報銷模式各不相同，高階晶體和雷射平台在歐洲部分地區迅速普及，而其他市場則優先考慮成本效益和公共採購管道。在這些地區，集中採購機制和國家臨床指南對設備採用時間表有顯著影響。

亞太地區是一個複雜的地區，既有大型白內障項目，也有快速現代化的私人醫療保健行業，而且該地區的醫療負擔能力仍然是主要限制因素。在亞太地區的多個市場，高手術量加上不斷成長的中階需求，正在刺激對擴充性超音波乳化系統和高階人工水晶體的投資，但供應商必須根據當地的報銷情況調整其服務模式和耗材定價。所有地區的通用包括培訓生態系統、供應鏈彈性和監管敏捷性日益重要。能夠調整區域市場策略以平衡成本、預期結果和基礎設施能力的製造商將佔據有利地位，並抓住多樣化的成長機會。

平台現有企業、鏡片創新者和軟體顛覆者之間的競爭動態和策略行動塑造了臨床應用和商業性優勢

白內障手術設備領域的公司層面動態呈現以下特點：成熟的平台提供者、專業人工水晶體創新者，以及專注於軟體驅動的手術計劃和耗材最佳化的靈活新參與企業。一直以來提供全平台解決方案的現有企業正在利用裝置量，提升銷售模組化升級、服務合約和培訓套餐，以深化臨床關係並確保持續的收益來源。同時，專業人工水晶體的開發人員正透過光學工程、先進材料科學和臨床證據，證明其為目標患者群體提供明顯的屈光優勢，脫穎而出。

新參與企業和醫療技術擴張企業正在透過引入可互通的規劃軟體、屈光結果的數位分析以及降低單例成本的供應鏈創新，挑戰傳統的界限。策略夥伴關係和分銷協議仍然是加速市場進入的首選途徑，尤其對於那些希望進入高度監管市場或擴展醫院網路的公司。此外，投資強大的臨床教育計畫和結果登記的組織往往能夠建立更強大的臨床醫生支持，並加速新技術的採用。最終，競爭優勢在於那些將產品創新與可證明的臨床效益、靈活的商業模式和可靠的售後支援相結合的公司。

加速技術採用、確保採購優勢、加強供應鏈和臨床支援能力的實用策略

對於尋求將情報轉化為影響力的行業領導者，一系列切實可行的建議可以加速臨床應用，增強供應鏈韌性，並最佳化商業性定位。首先，透過優先考慮能夠減少術中變異性、改善患者報告結果並融入現有手術工作流程的功能，使產品開發與檢驗的臨床需求保持一致。這樣做將使製造商能夠向外科醫生和採購委員會闡明其價值提案。其次，發展彈性價格設定和服務模式，以應對門診手術中心、醫院和專科診所不同的經濟狀況，並認知到每例病例的總成本和耗材物流通常會影響採購決策。

此外，多元化供應商網路並在高需求地區建立在局部庫存緩衝可以降低貿易和監管風險。投資於臨床醫生教育和全面的結果追蹤可帶來雙重益處。最後，透過開放的手術計畫和文件標準追求互通性，可以提高與醫院IT系統的兼容性，並降低採用門檻。這些措施共同構成了切實可行的藍圖，旨在提高市場接受度，同時減少醫療服務提供者和製造商的營運摩擦。

將主要臨床醫生和採購負責人的參與與二次證據綜合和嚴格的交叉檢驗程序相結合的調查方法框架

本報告背後的調查方法將系統性的一手資料研究與二手證據的綜合整合相結合，以確保獲得可靠且可操作的見解。主要方法包括對執業眼科醫師、醫院和門診中心的採購負責人以及負責平台整合的設備工程師進行結構化訪談。此外，我們也參觀了手術量較大的手術中心，並諮詢了監管專家，以確認設備是否符合批准和上市後要求。這些資訊來源的數據與同行評審文獻、臨床結果登記和設備標籤進行了交叉引用，以檢驗技術聲明和性能差距。

分析方法包括對臨床醫生優先事項的定性主題分析、供應商能力映射以及情境評估，以探索貿易政策變化和報銷變化的敏感性。品質保證步驟包括對訪談結果進行交叉檢驗、與臨床顧問共同審查調查方法，以及根據相關人員的回饋反覆完善假設。這些方法的結合提供了一個平衡的視角，整合了臨床判斷、營運現狀和監管環境，為讀者提供採購、產品開發和上市策略的實際指導。

整合臨床創新、營運適應性和供應鏈彈性，確保白內障護理的永續採用和競爭地位

最後，白內障手術設備正處於曲折點，技術創新、醫療服務分散化以及地緣政治因素共同影響臨床實務和商業策略。高精度雷射、先進的人工水晶體光學系統和數位化手術規劃正在擴大可實現的患者治療效果，而向門診治療的轉變則提升了吞吐量、設備相容性和耗材物流的重要性。同時，貿易政策的發展凸顯了全球供應鏈的脆弱性，並凸顯了本地製造和彈性採購的戰略價值。

因此，投資於循證產品差異化、強大的臨床醫生教育和富有韌性的供應生態系統的相關人員，將更有能力應對不確定性並抓住機會。透過將臨床優先事項與營運限制和監管環境結合，決策者可以製定策略，推動持續應用，改善患者治療效果，並在快速發展的市場環境中增強競爭地位。

目錄

第1章：前言

第2章調查方法

第3章執行摘要

第4章 市場概況

第5章 市場洞察

  • 擴大採用人工智慧驅動的生物識別分析系統來個性化選擇人工水晶體度數
  • 飛秒雷射輔助白內障手術與光學同調斷層掃描導引的快速發展
  • 開發並商業化可有效矯正老花眼並擴大景深、改善視力的人工水晶體。
  • 新興醫療保健市場的擴大推動了對可攜式超音波和手持式手術設備的需求
  • 引進遠距眼科平台和遠端監控技術進行白內障術後患者管理

第6章：2025年美國關稅的累積影響

第7章：人工智慧的累積影響，2025年

第8章白內障手術設備市場（依產品類型）

  • 飛秒雷射系統
  • 人工水晶體
    • 非人工水晶體
    • 擴大景深的人工水晶體
    • 單焦點人工水晶體
    • 多焦點人工水晶體
    • 人工水晶體
  • 眼部黏彈性裝置
  • 超音波乳化裝置
  • 手術耗材

第9章 白內障手術設備市場：依技術

  • 白內障囊外摘除術
  • 飛秒雷射輔助
    • 弓形切口
    • 囊切開術
    • 晶狀體碎裂
  • 手動小切口
  • 超音波

第 10 章白內障手術設備市場（依最終使用者）

  • 門診手術中心
  • 眼科研究所
  • 醫院
  • 眼科診所

第 11 章白內障手術設備市場：按地區

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第12章 白內障手術設備市場（依類別）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第13章 白內障手術設備市場（依國家）

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第14章競爭格局

  • 2024年市佔率分析
  • 2024年FPNV定位矩陣
  • 競爭分析
    • Alcon, Inc.
    • Johnson & Johnson Vision Care, Inc.
    • Bausch & Lomb Incorporated
    • HOYA Surgical Optics, Inc.
    • Carl Zeiss Meditec AG
    • STAAR Surgical Company
    • NIDEK Co., Ltd.
    • Rayner Intraocular Lenses Limited
    • PhysIOL SA
    • Lenstec, Inc.
Product Code: MRR-433AB1DC28B7

The Cataract Surgery Devices Market is projected to grow by USD 14.93 billion at a CAGR of 8.30% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 7.88 billion
Estimated Year [2025] USD 8.53 billion
Forecast Year [2032] USD 14.93 billion
CAGR (%) 8.30%

Framing the evolving cataract surgery device landscape in the context of clinical innovation, care setting shifts, and procurement imperatives

Cataract surgery devices occupy a pivotal position at the intersection of surgical innovation, demographic need, and healthcare delivery evolution. Over the past decade the field has advanced from reliance on conventional phacoemulsification and monofocal lenses toward a more diverse set of options that aim to improve refractive outcomes, reduce recovery times, and expand the settings in which procedures can be safely performed. These advances have been driven by parallel progress in imaging, laser precision, intraocular lens design, and consumables engineered to preserve ocular tissue and optimize intraoperative handling.

Consequently, clinical teams, procurement leaders, and device manufacturers are confronting a landscape that rewards interoperability, predictable supply chains, and a clear value proposition tied to clinical outcomes. As care pathways migrate from centralized hospitals to ambulatory surgery centers and specialty eye clinics, device selection increasingly reflects procedural throughput, compatibility with existing platforms, and support for emerging refractive technologies. In this context, a careful synthesis of device capabilities, regulatory trajectories, and end-user preferences is essential to inform purchasing strategies, clinical adoption, and product development roadmaps.

How precision lasers, diversified intraocular lens architectures, and care delivery decentralization are redefining clinical practice and supplier strategy

The cataract surgery device landscape is undergoing several transformative shifts that are reshaping clinical protocols, vendor strategies, and investment priorities. First, precision-guided femtosecond laser systems are altering the role of manual maneuvers by enabling more reproducible capsulotomies and targeted arcuate incisions, which in turn influence the selection of premium intraocular lenses and the expectation of refractive outcomes. In parallel, intraocular lens design has diversified beyond monofocal optics to include extended depth of focus, multifocal, toric, and advanced aspheric profiles, thereby broadening the patient populations and reimbursement conversations around premium care.

Simultaneously, the operational footprint of cataract care is shifting toward ambulatory surgery centers and high-volume ophthalmology clinics where throughput and device compatibility matter as much as instrument performance. This decentralization encourages device makers to prioritize modular systems, streamlined consumable logistics, and training packages that reduce variability in surgical results. Finally, digital integration-ranging from perioperative imaging to surgical planning software and interoperability with electronic health records-is emerging as a differentiator. Taken together, these shifts favor suppliers who can demonstrate clinical advantage, economic clarity, and an ability to integrate seamlessly into diverse care pathways.

Examining the operational and procurement consequences of U.S. tariff measures in 2025 and their implications for device sourcing and clinical adoption

Recent tariff actions and the broader trade policy environment in the United States in 2025 have created material reverberations across supply chains for cataract surgery devices, prompting manufacturers and providers to reassess sourcing strategies and cost structures. Because many devices and key components are manufactured across multiple geographies, incremental import levies have initiated a cascade of responses: some suppliers absorbed costs temporarily to preserve market access, others shifted procurement toward domestic or tariff-exempt suppliers, and a subset accelerated localization of critical subassemblies. As a result, purchasing timelines and vendor negotiations incorporated more explicit contingency clauses and near-term risk assessments.

Beyond direct cost implications, tariffs have influenced clinical adoption pathways by altering the relative price of premium intraocular lenses, femtosecond laser modules, and high-end phacoemulsification consoles. Healthcare systems pursuing predictable budgeting placed higher value on multi-year service agreements and bundled pricing, while ambulatory centers emphasized total cost per case and consumable availability. Importantly, regulatory alignment and expedited customs processes emerged as operational levers; manufacturers that demonstrated robust compliance documentation, local warehousing, and rapid replacement capability gained competitive advantage. Looking forward, these dynamics are likely to persist unless trade policies stabilize, underscoring the need for diversified supplier relationships and transparent price modeling within procurement strategies.

Detailed segmentation insights showing how product types, technology workflows, and care settings determine adoption patterns, training needs, and procurement priorities

Critical segmentation insights reveal how product design, procedural technology, and end-user setting jointly shape adoption patterns and investment priorities in cataract surgery devices. First, examining product type shows a continuum from high-capital platforms like femtosecond laser systems to consumables and phaco consoles. Intraocular lenses occupy a central role within this spectrum and further differentiate into aspheric designs aimed at image quality optimization, extended depth of focus lenses that broaden functional vision, monofocal lenses that remain the pragmatic default, multifocal solutions intended for spectacle independence, and toric lenses that address astigmatism correction. Each subcategory imposes distinct clinical training requirements and influences postoperative patient satisfaction metrics.

Turning to technology-based segmentation, there is a clear divide between extracapsular cataract extraction methods and more contemporary approaches such as femtosecond laser assisted surgery, manual small incision techniques, and phacoemulsification. Within femtosecond-assisted workflows, procedural modules like arcuate incisions for astigmatism management, capsulotomy for consistent lens centration, and lens fragmentation for reduced phaco energy are driving complementary device purchases and procedural standardization. Finally, end-user segmentation demonstrates differentiated purchasing priorities: ambulatory surgery centers and ophthalmology clinics often prioritize throughput, instrument footprint, and consumable logistics; eye institutes focus on research-grade versatility and clinical trial readiness; hospitals emphasize breadth of service and cross-specialty integration. Together, these segmentation axes indicate that successful commercial strategies must align product modularity, training support, and service models with the unique operational realities of each care setting.

How regional reimbursement models, surgical volumes, and infrastructure differences across the Americas, Europe Middle East & Africa, and Asia-Pacific shape device strategies

Regional dynamics remain a primary determinant of device distribution strategies and commercialization approaches across the global cataract ecosystem. In the Americas, strong private payer participation combined with an extensive network of ambulatory surgery centers creates demand for devices that deliver throughput efficiency, predictable outcomes, and strong post-sale service. Conversely, institutional purchasing in the Americas often demands integrated platform compatibility and clear clinical-economic rationale to support capital investment decisions. Moving to Europe, Middle East & Africa, the region exhibits heterogenous regulatory environments and reimbursement models, with parts of Europe demonstrating rapid uptake of premium lenses and laser platforms while other markets prioritize cost-effectiveness and public procurement channels. In these territories, centralized procurement mechanisms and national clinical guidelines significantly influence adoption timelines.

Asia-Pacific presents a complex mix of high-volume cataract programs, rapidly modernizing private healthcare sectors, and regions where affordability remains the primary constraint. In several Asia-Pacific markets, the combination of high surgical volume and growing middle-class demand is spurring investment in both scalable phaco systems and premium IOL options, but suppliers must tailor service models and consumable pricing to local reimbursement realities. Across all regions, common threads include the rising importance of training ecosystems, supply chain resilience, and regulatory agility. Manufacturers that adapt regional go-to-market strategies to the local balance between cost, outcome expectations, and infrastructure capacity will be better positioned to capture diverse growth opportunities.

Competitive dynamics and strategic behaviors among platform incumbents, lens innovators, and software disruptors shaping clinical adoption and commercial advantage

Company-level dynamics in the cataract devices space are characterized by a combination of incumbent platform providers, specialized lens innovators, and agile newcomers focused on software-enabled surgical planning and consumables optimization. Incumbents that have historically delivered full-platform solutions are leveraging installed bases to upsell modular upgrades, service agreements, and training packages, thereby deepening clinical relationships and securing recurring revenue streams. At the same time, specialized intraocular lens developers are differentiating through optical engineering, premium material science, and clinical evidence that demonstrates distinct refractive advantages for targeted patient cohorts.

Newer entrants and medtech scale-ups are challenging traditional boundaries by introducing interoperable planning software, digital analytics for refractive outcomes, and supply chain innovations that reduce per-case costs. Strategic partnerships and distribution agreements remain preferred routes to accelerate market access, particularly for companies seeking to enter highly regulated markets or to expand hospital networks. Moreover, organizations that invest in robust clinical education programs and outcome registries tend to build stronger clinician advocacy and faster uptake of newer technologies. Ultimately, competitive advantage accrues to companies that align product innovation with demonstrable clinical benefit, flexible commercial models, and proven post-sale support.

Practical strategic recommendations to accelerate technology adoption, secure procurement advantage, and enhance supply chain and clinical support capabilities

For industry leaders seeking to translate intelligence into impact, a set of actionable recommendations can expedite clinical adoption, strengthen supply chain resilience, and optimize commercial positioning. First, align product development with validated clinical needs by prioritizing features that reduce intraoperative variability, improve patient-reported outcomes, and integrate into existing surgical workflows. By doing so, manufacturers will make the value proposition clearer to both surgeons and procurement committees. Second, develop flexible pricing and service models that accommodate the distinct economics of ambulatory surgery centers, hospitals, and specialty clinics, recognizing that total cost per case and consumable logistics are frequently decisive in purchase decisions.

Additionally, mitigate trade and regulatory risk by diversifying supplier networks and establishing localized inventory buffers in high-demand regions. Investing in clinician education and comprehensive outcome tracking provides a dual benefit: it accelerates evidence generation needed for premium device adoption and strengthens post-market surveillance. Finally, pursue interoperability through open standards for surgical planning and documentation, which will enhance compatibility with hospital IT systems and reduce barriers to adoption. Taken together, these steps create a practical roadmap for improving market receptivity while reducing operational friction for both providers and manufacturers.

Methodological framework combining primary clinician and procurement engagement with secondary evidence synthesis and rigorous cross-validation procedures

The research methodology underpinning this report combines systematic primary engagement with secondary evidence synthesis to ensure robust, actionable insights. Primary methods included structured interviews with practicing ophthalmic surgeons, procurement leaders across hospitals and ambulatory centers, and device engineers responsible for platform integration. These engagements were complemented by site visits to high-volume surgical centers and consultations with regulatory specialists to verify device clearances and post-market requirements. Data from these sources were triangulated with peer-reviewed literature, clinical outcome registries, and device labeling to validate technical claims and performance differentials.

Analytical approaches encompassed qualitative thematic analysis of clinician priorities, supplier capability mapping, and scenario assessments to explore sensitivity to trade policy shifts and reimbursement changes. Quality assurance steps included cross-validation of interview findings, review of methodology by clinical advisors, and iterative refinement of assumptions through stakeholder feedback. Together, these methods produced a balanced view that integrates clinical judgment, operational realities, and regulatory context, enabling readers to derive practical implications for procurement, product development, and market entry strategies.

Integrating clinical innovation, operational adaptability, and supply chain resilience to secure sustainable adoption and competitive positioning in cataract therapy

In closing, cataract surgery devices are at an inflection point where technological innovation, care delivery decentralization, and geopolitical factors collectively influence clinical practice and commercial strategy. Precision lasers, advanced intraocular lens optics, and digital surgical planning are expanding the set of achievable patient outcomes, while shifts toward ambulatory settings elevate the importance of throughput, device compatibility, and consumable logistics. Concurrently, trade policy developments have underscored the vulnerability of global supply chains and the strategic value of localized manufacturing and flexible procurement arrangements.

Therefore, stakeholders who invest in evidence-based product differentiation, robust clinician education, and resilient supply ecosystems will be better equipped to navigate uncertainty and capitalize on opportunities. By synthesizing clinical priorities with operational constraints and regulatory considerations, decision-makers can craft strategies that promote sustainable adoption, improve patient outcomes, and strengthen competitive positioning in a rapidly evolving landscape.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. The increasing adoption of artificial intelligence-driven biometric analysis systems for personalized intraocular lens power selection
  • 5.2. Rapid growth of femtosecond laser-assisted cataract surgery integrated with optical coherence tomography guidance
  • 5.3. Development and commercialization of advanced presbyopia-correcting and extended depth of focus intraocular lenses with improved visual outcomes
  • 5.4. Rising demand for portable phacoemulsification units and hand-held surgical devices to expand access in emerging healthcare markets
  • 5.5. Implementation of teleophthalmology platforms and remote monitoring technologies for postoperative cataract surgery patient management

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Cataract Surgery Devices Market, by Product Type

  • 8.1. Femtosecond Laser Systems
  • 8.2. Intraocular Lenses
    • 8.2.1. Aspheric Iols
    • 8.2.2. Extended Depth Of Focus Iols
    • 8.2.3. Monofocal Iols
    • 8.2.4. Multifocal Iols
    • 8.2.5. Toric Iols
  • 8.3. Ocular Viscoelastic Devices
  • 8.4. Phacoemulsification Equipment
  • 8.5. Surgical Consumables

9. Cataract Surgery Devices Market, by Technology

  • 9.1. Extracapsular Cataract Extraction
  • 9.2. Femtosecond Laser Assisted
    • 9.2.1. Arcuate Incisions
    • 9.2.2. Capsulotomy
    • 9.2.3. Lens Fragmentation
  • 9.3. Manual Small Incision
  • 9.4. Phacoemulsification

10. Cataract Surgery Devices Market, by End User

  • 10.1. Ambulatory Surgery Centers
  • 10.2. Eye Institutes
  • 10.3. Hospitals
  • 10.4. Ophthalmology Clinics

11. Cataract Surgery Devices Market, by Region

  • 11.1. Americas
    • 11.1.1. North America
    • 11.1.2. Latin America
  • 11.2. Europe, Middle East & Africa
    • 11.2.1. Europe
    • 11.2.2. Middle East
    • 11.2.3. Africa
  • 11.3. Asia-Pacific

12. Cataract Surgery Devices Market, by Group

  • 12.1. ASEAN
  • 12.2. GCC
  • 12.3. European Union
  • 12.4. BRICS
  • 12.5. G7
  • 12.6. NATO

13. Cataract Surgery Devices Market, by Country

  • 13.1. United States
  • 13.2. Canada
  • 13.3. Mexico
  • 13.4. Brazil
  • 13.5. United Kingdom
  • 13.6. Germany
  • 13.7. France
  • 13.8. Russia
  • 13.9. Italy
  • 13.10. Spain
  • 13.11. China
  • 13.12. India
  • 13.13. Japan
  • 13.14. Australia
  • 13.15. South Korea

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2024
  • 14.2. FPNV Positioning Matrix, 2024
  • 14.3. Competitive Analysis
    • 14.3.1. Alcon, Inc.
    • 14.3.2. Johnson & Johnson Vision Care, Inc.
    • 14.3.3. Bausch & Lomb Incorporated
    • 14.3.4. HOYA Surgical Optics, Inc.
    • 14.3.5. Carl Zeiss Meditec AG
    • 14.3.6. STAAR Surgical Company
    • 14.3.7. NIDEK Co., Ltd.
    • 14.3.8. Rayner Intraocular Lenses Limited
    • 14.3.9. PhysIOL SA
    • 14.3.10. Lenstec, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 9. AMERICAS CATARACT SURGERY DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. NORTH AMERICA CATARACT SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. LATIN AMERICA CATARACT SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. EUROPE, MIDDLE EAST & AFRICA CATARACT SURGERY DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. EUROPE CATARACT SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. MIDDLE EAST CATARACT SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. AFRICA CATARACT SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC CATARACT SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASEAN CATARACT SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GCC CATARACT SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. EUROPEAN UNION CATARACT SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. BRICS CATARACT SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. G7 CATARACT SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. NATO CATARACT SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. CATARACT SURGERY DEVICES MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 26. CATARACT SURGERY DEVICES MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. CATARACT SURGERY DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY FEMTOSECOND LASER SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY FEMTOSECOND LASER SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY FEMTOSECOND LASER SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY FEMTOSECOND LASER SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY FEMTOSECOND LASER SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY FEMTOSECOND LASER SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY INTRAOCULAR LENSES, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY INTRAOCULAR LENSES, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY INTRAOCULAR LENSES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY INTRAOCULAR LENSES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY INTRAOCULAR LENSES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY INTRAOCULAR LENSES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY INTRAOCULAR LENSES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY INTRAOCULAR LENSES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY ASPHERIC IOLS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY ASPHERIC IOLS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY ASPHERIC IOLS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY ASPHERIC IOLS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY ASPHERIC IOLS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY ASPHERIC IOLS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY EXTENDED DEPTH OF FOCUS IOLS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY EXTENDED DEPTH OF FOCUS IOLS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY EXTENDED DEPTH OF FOCUS IOLS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY EXTENDED DEPTH OF FOCUS IOLS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY EXTENDED DEPTH OF FOCUS IOLS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY EXTENDED DEPTH OF FOCUS IOLS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY MONOFOCAL IOLS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY MONOFOCAL IOLS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY MONOFOCAL IOLS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY MONOFOCAL IOLS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY MONOFOCAL IOLS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY MONOFOCAL IOLS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY MULTIFOCAL IOLS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY MULTIFOCAL IOLS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY MULTIFOCAL IOLS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY MULTIFOCAL IOLS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY MULTIFOCAL IOLS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY MULTIFOCAL IOLS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY TORIC IOLS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY TORIC IOLS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY TORIC IOLS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY TORIC IOLS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY TORIC IOLS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY TORIC IOLS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY OCULAR VISCOELASTIC DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY OCULAR VISCOELASTIC DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY OCULAR VISCOELASTIC DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY OCULAR VISCOELASTIC DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY OCULAR VISCOELASTIC DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY OCULAR VISCOELASTIC DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY PHACOEMULSIFICATION EQUIPMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY PHACOEMULSIFICATION EQUIPMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY PHACOEMULSIFICATION EQUIPMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY PHACOEMULSIFICATION EQUIPMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY PHACOEMULSIFICATION EQUIPMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY PHACOEMULSIFICATION EQUIPMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY SURGICAL CONSUMABLES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY SURGICAL CONSUMABLES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY SURGICAL CONSUMABLES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY SURGICAL CONSUMABLES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY SURGICAL CONSUMABLES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY SURGICAL CONSUMABLES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY EXTRACAPSULAR CATARACT EXTRACTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY EXTRACAPSULAR CATARACT EXTRACTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY EXTRACAPSULAR CATARACT EXTRACTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY EXTRACAPSULAR CATARACT EXTRACTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY EXTRACAPSULAR CATARACT EXTRACTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY EXTRACAPSULAR CATARACT EXTRACTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY FEMTOSECOND LASER ASSISTED, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY FEMTOSECOND LASER ASSISTED, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY FEMTOSECOND LASER ASSISTED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY FEMTOSECOND LASER ASSISTED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY FEMTOSECOND LASER ASSISTED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY FEMTOSECOND LASER ASSISTED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY FEMTOSECOND LASER ASSISTED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY FEMTOSECOND LASER ASSISTED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY ARCUATE INCISIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY ARCUATE INCISIONS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY ARCUATE INCISIONS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY ARCUATE INCISIONS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY ARCUATE INCISIONS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY ARCUATE INCISIONS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY CAPSULOTOMY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY CAPSULOTOMY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY CAPSULOTOMY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY CAPSULOTOMY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY CAPSULOTOMY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY CAPSULOTOMY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY LENS FRAGMENTATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY LENS FRAGMENTATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY LENS FRAGMENTATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY LENS FRAGMENTATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY LENS FRAGMENTATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY LENS FRAGMENTATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY MANUAL SMALL INCISION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY MANUAL SMALL INCISION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY MANUAL SMALL INCISION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY MANUAL SMALL INCISION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY MANUAL SMALL INCISION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY MANUAL SMALL INCISION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY PHACOEMULSIFICATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY PHACOEMULSIFICATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY PHACOEMULSIFICATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY PHACOEMULSIFICATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY PHACOEMULSIFICATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY PHACOEMULSIFICATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY EYE INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY EYE INSTITUTES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY EYE INSTITUTES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY EYE INSTITUTES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY EYE INSTITUTES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY EYE INSTITUTES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY OPHTHALMOLOGY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY OPHTHALMOLOGY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY OPHTHALMOLOGY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY OPHTHALMOLOGY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY OPHTHALMOLOGY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY OPHTHALMOLOGY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 143. AMERICAS CATARACT SURGERY DEVICES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 144. AMERICAS CATARACT SURGERY DEVICES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 145. AMERICAS CATARACT SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 146. AMERICAS CATARACT SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 147. AMERICAS CATARACT SURGERY DEVICES MARKET SIZE, BY INTRAOCULAR LENSES, 2018-2024 (USD MILLION)
  • TABLE 148. AMERICAS CATARACT SURGERY DEVICES MARKET SIZE, BY INTRAOCULAR LENSES, 2025-2032 (USD MILLION)
  • TABLE 149. AMERICAS CATARACT SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 150. AMERICAS CATARACT SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 151. AMERICAS CATARACT SURGERY DEVICES MARKET SIZE, BY FEMTOSECOND LASER ASSISTED, 2018-2024 (USD MILLION)
  • TABLE 152. AMERICAS CATARACT SURGERY DEVICES MARKET SIZE, BY FEMTOSECOND LASER ASSISTED, 2025-2032 (USD MILLION)
  • TABLE 153. AMERICAS CATARACT SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 154. AMERICAS CATARACT SURGERY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 155. NORTH AMERICA CATARACT SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 156. NORTH AMERICA CATARACT SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 157. NORTH AMERICA CATARACT SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 158. NORTH AMERICA CATARACT SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 159. NORTH AMERICA CATARACT SURGERY DEVICES MARKET SIZE, BY INTRAOCULAR LENSES, 2018-2024 (USD MILLION)
  • TABLE 160. NORTH AMERICA CATARACT SURGERY DEVICES MARKET SIZE, BY INTRAOCULAR LENSES, 2025-2032 (USD MILLION)
  • TABLE 161. NORTH AMERICA CATARACT SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 162. NORTH AMERICA CATARACT SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 163. NORTH AMERICA CATARACT SURGERY DEVICES MARKET SIZE, BY FEMTOSECOND LASER ASSISTED, 2018-2024 (USD MILLION)
  • TABLE 164. NORTH AMERICA CATARACT SURGERY DEVICES MARKET SIZE, BY FEMTOSECOND LASER ASSISTED, 2025-2032 (USD MILLION)
  • TABLE 165. NORTH AMERICA CATARACT SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 166. NORTH AMERICA CATARACT SURGERY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 167. LATIN AMERICA CATARACT SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 168. LATIN AMERICA CATARACT SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 169. LATIN AMERICA CATARACT SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 170. LATIN AMERICA CATARACT SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 171. LATIN AMERICA CATARACT SURGERY DEVICES MARKET SIZE, BY INTRAOCULAR LENSES, 2018-2024 (USD MILLION)
  • TABLE 172. LATIN AMERICA CATARACT SURGERY DEVICES MARKET SIZE, BY INTRAOCULAR LENSES, 2025-2032 (USD MILLION)
  • TABLE 173. LATIN AMERICA CATARACT SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 174. LATIN AMERICA CATARACT SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 175. LATIN AMERICA CATARACT SURGERY DEVICES MARKET SIZE, BY FEMTOSECOND LASER ASSISTED, 2018-2024 (USD MILLION)
  • TABLE 176. LATIN AMERICA CATARACT SURGERY DEVICES MARKET SIZE, BY FEMTOSECOND LASER ASSISTED, 2025-2032 (USD MILLION)
  • TABLE 177. LATIN AMERICA CATARACT SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 178. LATIN AMERICA CATARACT SURGERY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 179. EUROPE, MIDDLE EAST & AFRICA CATARACT SURGERY DEVICES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 180. EUROPE, MIDDLE EAST & AFRICA CATARACT SURGERY DEVICES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 181. EUROPE, MIDDLE EAST & AFRICA CATARACT SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 182. EUROPE, MIDDLE EAST & AFRICA CATARACT SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 183. EUROPE, MIDDLE EAST & AFRICA CATARACT SURGERY DEVICES MARKET SIZE, BY INTRAOCULAR LENSES, 2018-2024 (USD MILLION)
  • TABLE 184. EUROPE, MIDDLE EAST & AFRICA CATARACT SURGERY DEVICES MARKET SIZE, BY INTRAOCULAR LENSES, 2025-2032 (USD MILLION)
  • TABLE 185. EUROPE, MIDDLE EAST & AFRICA CATARACT SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 186. EUROPE, MIDDLE EAST & AFRICA CATARACT SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 187. EUROPE, MIDDLE EAST & AFRICA CATARACT SURGERY DEVICES MARKET SIZE, BY FEMTOSECOND LASER ASSISTED, 2018-2024 (USD MILLION)
  • TABLE 188. EUROPE, MIDDLE EAST & AFRICA CATARACT SURGERY DEVICES MARKET SIZE, BY FEMTOSECOND LASER ASSISTED, 2025-2032 (USD MILLION)
  • TABLE 189. EUROPE, MIDDLE EAST & AFRICA CATARACT SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 190. EUROPE, MIDDLE EAST & AFRICA CATARACT SURGERY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 191. EUROPE CATARACT SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 192. EUROPE CATARACT SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 193. EUROPE CATARACT SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 194. EUROPE CATARACT SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 195. EUROPE CATARACT SURGERY DEVICES MARKET SIZE, BY INTRAOCULAR LENSES, 2018-2024 (USD MILLION)
  • TABLE 196. EUROPE CATARACT SURGERY DEVICES MARKET SIZE, BY INTRAOCULAR LENSES, 2025-2032 (USD MILLION)
  • TABLE 197. EUROPE CATARACT SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 198. EUROPE CATARACT SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 199. EUROPE CATARACT SURGERY DEVICES MARKET SIZE, BY FEMTOSECOND LASER ASSISTED, 2018-2024 (USD MILLION)
  • TABLE 200. EUROPE CATARACT SURGERY DEVICES MARKET SIZE, BY FEMTOSECOND LASER ASSISTED, 2025-2032 (USD MILLION)
  • TABLE 201. EUROPE CATARACT SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 202. EUROPE CATARACT SURGERY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 203. MIDDLE EAST CATARACT SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 204. MIDDLE EAST CATARACT SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 205. MIDDLE EAST CATARACT SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 206. MIDDLE EAST CATARACT SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 207. MIDDLE EAST CATARACT SURGERY DEVICES MARKET SIZE, BY INTRAOCULAR LENSES, 2018-2024 (USD MILLION)
  • TABLE 208. MIDDLE EAST CATARACT SURGERY DEVICES MARKET SIZE, BY INTRAOCULAR LENSES, 2025-2032 (USD MILLION)
  • TABLE 209. MIDDLE EAST CATARACT SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 210. MIDDLE EAST CATARACT SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 211. MIDDLE EAST CATARACT SURGERY DEVICES MARKET SIZE, BY FEMTOSECOND LASER ASSISTED, 2018-2024 (USD MILLION)
  • TABLE 212. MIDDLE EAST CATARACT SURGERY DEVICES MARKET SIZE, BY FEMTOSECOND LASER ASSISTED, 2025-2032 (USD MILLION)
  • TABLE 213. MIDDLE EAST CATARACT SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 214. MIDDLE EAST CATARACT SURGERY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 215. AFRICA CATARACT SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 216. AFRICA CATARACT SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 217. AFRICA CATARACT SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 218. AFRICA CATARACT SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 219. AFRICA CATARACT SURGERY DEVICES MARKET SIZE, BY INTRAOCULAR LENSES, 2018-2024 (USD MILLION)
  • TABLE 220. AFRICA CATARACT SURGERY DEVICES MARKET SIZE, BY INTRAOCULAR LENSES, 2025-2032 (USD MILLION)
  • TABLE 221. AFRICA CATARACT SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 222. AFRICA CATARACT SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 223. AFRICA CATARACT SURGERY DEVICES MARKET SIZE, BY FEMTOSECOND LASER ASSISTED, 2018-2024 (USD MILLION)
  • TABLE 224. AFRICA CATARACT SURGERY DEVICES MARKET SIZE, BY FEMTOSECOND LASER ASSISTED, 2025-2032 (USD MILLION)
  • TABLE 225. AFRICA CATARACT SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 226. AFRICA CATARACT SURGERY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 227. ASIA-PACIFIC CATARACT SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 228. ASIA-PACIFIC CATARACT SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 229. ASIA-PACIFIC CATARACT SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 230. ASIA-PACIFIC CATARACT SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 231. ASIA-PACIFIC CATARACT SURGERY DEVICES MARKET SIZE, BY INTRAOCULAR LENSES, 2018-2024 (USD MILLION)
  • TABLE 232. ASIA-PACIFIC CATARACT SURGERY DEVICES MARKET SIZE, BY INTRAOCULAR LENSES, 2025-2032 (USD MILLION)
  • TABLE 233. ASIA-PACIFIC CATARACT SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 234. ASIA-PACIFIC CATARACT SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 235. ASIA-PACIFIC CATARACT SURGERY DEVICES MARKET SIZE, BY FEMTOSECOND LASER ASSISTED, 2018-2024 (USD MILLION)
  • TABLE 236. ASIA-PACIFIC CATARACT SURGERY DEVICES MARKET SIZE, BY FEMTOSECOND LASER ASSISTED, 2025-2032 (USD MILLION)
  • TABLE 237. ASIA-PACIFIC CATARACT SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 238. ASIA-PACIFIC CATARACT SURGERY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 239. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 240. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 241. ASEAN CATARACT SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 242. ASEAN CATARACT SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 243. ASEAN CATARACT SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 244. ASEAN CATARACT SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 245. ASEAN CATARACT SURGERY DEVICES MARKET SIZE, BY INTRAOCULAR LENSES, 2018-2024 (USD MILLION)
  • TABLE 246. ASEAN CATARACT SURGERY DEVICES MARKET SIZE, BY INTRAOCULAR LENSES, 2025-2032 (USD MILLION)
  • TABLE 247. ASEAN CATARACT SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 248. ASEAN CATARACT SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 249. ASEAN CATARACT SURGERY DEVICES MARKET SIZE, BY FEMTOSECOND LASER ASSISTED, 2018-2024 (USD MILLION)
  • TABLE 250. ASEAN CATARACT SURGERY DEVICES MARKET SIZE, BY FEMTOSECOND LASER ASSISTED, 2025-2032 (USD MILLION)
  • TABLE 251. ASEAN CATARACT SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 252. ASEAN CATARACT SURGERY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 253. GCC CATARACT SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 254. GCC CATARACT SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 255. GCC CATARACT SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 256. GCC CATARACT SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 257. GCC CATARACT SURGERY DEVICES MARKET SIZE, BY INTRAOCULAR LENSES, 2018-2024 (USD MILLION)
  • TABLE 258. GCC CATARACT SURGERY DEVICES MARKET SIZE, BY INTRAOCULAR LENSES, 2025-2032 (USD MILLION)
  • TABLE 259. GCC CATARACT SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 260. GCC CATARACT SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 261. GCC CATARACT SURGERY DEVICES MARKET SIZE, BY FEMTOSECOND LASER ASSISTED, 2018-2024 (USD MILLION)
  • TABLE 262. GCC CATARACT SURGERY DEVICES MARKET SIZE, BY FEMTOSECOND LASER ASSISTED, 2025-2032 (USD MILLION)
  • TABLE 263. GCC CATARACT SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 264. GCC CATARACT SURGERY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 265. EUROPEAN UNION CATARACT SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 266. EUROPEAN UNION CATARACT SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 267. EUROPEAN UNION CATARACT SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 268. EUROPEAN UNION CATARACT SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 269. EUROPEAN UNION CATARACT SURGERY DEVICES MARKET SIZE, BY INTRAOCULAR LENSES, 2018-2024 (USD MILLION)
  • TABLE 270. EUROPEAN UNION CATARACT SURGERY DEVICES MARKET SIZE, BY INTRAOCULAR LENSES, 2025-2032 (USD MILLION)
  • TABLE 271. EUROPEAN UNION CATARACT SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 272. EUROPEAN UNION CATARACT SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 273. EUROPEAN UNION CATARACT SURGERY DEVICES MARKET SIZE, BY FEMTOSECOND LASER ASSISTED, 2018-2024 (USD MILLION)
  • TABLE 274. EUROPEAN UNION CATARACT SURGERY DEVICES MARKET SIZE, BY FEMTOSECOND LASER ASSISTED, 2025-2032 (USD MILLION)
  • TABLE 275. EUROPEAN UNION CATARACT SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 276. EUROPEAN UNION CATARACT SURGERY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 277. BRICS CATARACT SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 278. BRICS CATARACT SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 279. BRICS CATARACT SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 280. BRICS CATARACT SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 281. BRICS CATARACT SURGERY DEVICES MARKET SIZE, BY INTRAOCULAR LENSES, 2018-2024 (USD MILLION)
  • TABLE 282. BRICS CATARACT SURGERY DEVICES MARKET SIZE, BY INTRAOCULAR LENSES, 2025-2032 (USD MILLION)
  • TABLE 283. BRICS CATARACT SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 284. BRICS CATARACT SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 285. BRICS CATARACT SURGERY DEVICES MARKET SIZE, BY FEMTOSECOND LASER ASSISTED, 2018-2024 (USD MILLION)
  • TABLE 286. BRICS CATARACT SURGERY DEVICES MARKET SIZE, BY FEMTOSECOND LASER ASSISTED, 2025-2032 (USD MILLION)
  • TABLE 287. BRICS CATARACT SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 288. BRICS CATARACT SURGERY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 289. G7 CATARACT SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 290. G7 CATARACT SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 291. G7 CATARACT SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 292. G7 CATARACT SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 293. G7 CATARACT SURGERY DEVICES MARKET SIZE, BY INTRAOCULAR LENSES, 2018-2024 (USD MILLION)
  • TABLE 294. G7 CATARACT SURGERY DEVICES MARKET SIZE, BY INTRAOCULAR LENSES, 2025-2032 (USD MILLION)
  • TABLE 295. G7 CATARACT SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 296. G7 CATARACT SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 297. G7 CATARACT SURGERY DEVICES MARKET SIZE, BY FEMTOSECOND LASER ASSISTED, 2018-2024 (USD MILLION)
  • TABLE 298. G7 CATARACT SURGERY DEVICES MARKET SIZE, BY FEMTOSECOND LASER ASSISTED, 2025-2032 (USD MILLION)
  • TABLE 299. G7 CATARACT SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 300. G7 CATARACT SURGERY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 301. NATO CATARACT SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 302. NATO CATARACT SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 303. NATO CATARACT SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 304. NATO CATARACT SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 305. NATO CATARACT SURGERY DEVICES MARKET SIZE, BY INTRAOCULAR LENSES, 2018-2024 (USD MILLION)
  • TABLE 306. NATO CATARACT SURGERY DEVICES MARKET SIZE, BY INTRAOCULAR LENSES, 2025-2032 (USD MILLION)
  • TABLE 307. NATO CATARACT SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 308. NATO CATARACT SURGERY D